This year, beauty technology company Cutera filed for a prepackaged Chapter 11 bankruptcy on March 5 to reduce its debt by ...

Dr. Garshick suggests pairing tretinoin with hyaluronic acid and ceramides to combat any dryness or irritation that you might ...

Key Points Hims & Hers Health is entering the Canadian market.The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there.10 stocks we ...

Hims & Hers bounced back by 8.64 percent on Monday to close at $52.03 following announcements that it remains open to working with Novo Nordisk in the future despite the termination of its earlier ...

The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & Hers Health (NYSE: HIMS) is a top telehealth stock that has been ...

Hims & Hers Health, Inc.’s HIMS investors have been experiencing some short-term gains from the stock lately despite its bumpy ride over recent months. The San Francisco, CA-based health and ...

Hims & Hers Health, Inc. (NYSE:HIMS) is a well-known digital health platform that allows users to order medicines after securing prescriptions.

Hims & Hers Health, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Wolf Haldenstein Before August 25, 2025 to Discuss Your Rights ...

Hims & Hers Health is entering the Canadian market. The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there.